Sheldon H. Preskorn
Clinical Research Institute
Wichita
KS 67211
USA
Name/email consistency: high
- Comparison of the pharmacokinetics of venlafaxine extended release and desvenlafaxine in extensive and poor cytochrome P450 2D6 metabolizers. Preskorn, S., Patroneva, A., Silman, H., Jiang, Q., Isler, J.A., Burczynski, M.E., Ahmed, S., Paul, J., Nichols, A.I. J. Clin. Psychopharmacol (2009)
- An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder. Preskorn, S.H., Baker, B., Kolluri, S., Menniti, F.S., Krams, M., Landen, J.W. J. Clin. Psychopharmacol (2008)
- Effect of desvenlafaxine on the cytochrome P450 2D6 enzyme system. Preskorn, S.H., Nichols, A.I., Paul, J., Patroneva, A.L., Helzner, E.C., Guico-Pabia, C.J. J. Psychiatr. Pract (2008)
- Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteers. Preskorn, S.H., Greenblatt, D.J., Flockhart, D., Luo, Y., Perloff, E.S., Harmatz, J.S., Baker, B., Klick-Davis, A., Desta, Z., Burt, T. J. Clin. Psychopharmacol (2007)
- The potential for clinically significant drug-drug interactions involving the CYP 2D6 system: effects with fluoxetine and paroxetine versus sertraline. Preskorn, S.H., Shah, R., Neff, M., Golbeck, A.L., Choi, J. J. Psychiatr. Pract (2007)
